News
A new drug delivery system developed by researchers at the University of Hawaiʻi at Mānoa John A. Burns School of Medicine ...
People with chronic lymphocytic leukemia (CLL) saw a 55% year-to-year increase in all-cause mortality in the early days of ...
Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It ...
("Checkpoint"), an immunotherapy and targeted oncology company. As part of the acquisition, Sun Pharma acquires UNLOXCYT™, ...
Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations Seventy-six patients with LL-mCRC were retrospectively included. DNA from tumor tissue was sequenced, ...
She serves on WHO's Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) Five years ago, COVID was all we could think about. Today, we’d rather forget about ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Five years ago, COVID was all we could think about. Today, we'd rather forget about lockdowns, testing lines and social distancing. But the virus that sparked the pandemic, SARS-CoV-2, is still ...
Even mild COVID-19 cases can trigger lingering symptoms, especially in women and younger adults, while severe cases show a strong link to long-term fatigue, brain fog, and joint pain, setting ...
What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...
Scientist who pushed for COVID lab leak theory investigation says high-risk research needs oversight
Five years after the COVID pandemic started, a scientist who warned against dismissing the controversial "lab leak" theory says more needs to be done to prevent high-risk research from potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results